Syneos Health slashes revenue target amid biotech struggles; stock slides

One the Triangle's largest contract research organizations is lowering its revenue expectations for 2022 as the life sciences industry hits speed bumps.

Source: bizjournals.com Health Care:Biotechnology headlines - August 3, 2022 Category: Biotechnology Authors: Zac Ezzone Source Type: news